MMJ Group investee Embark Health continues delivering on business strategic priorities for 2021 with supply agreements and sales execution
Embark continues to work toward a public listing in 2021 after deciding to pursue a direct listing of Mesa Exploration on March 11. Embark Health is a leader in solventless cannabis extraction with a focus on production of 2.0 products for the B2B, medical and adult-use markets.
MMJ Group Holdings Ltd (ASX:MMJ) (OTCMKTS:MMJJF) investee Embark Health Inc has continued to deliver its strategic business development priorities on several fronts during the first 11 weeks of 2021, including entering into supply agreements with the provincial boards of British Columbia, Alberta and Manitoba.
MMJ Group Holdings Ltd investee Embark Health Inc continues delivering on business strategic priorities for 2021 with supply agreements and sales execution proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Embark Health Inc. Enters into Supply Agreement with Shelter Market for the Canadian Medical Market
Embark or the
Company ) is pleased to announce they have entered into an agreement with Shelter Market, a medical cannabis marketplace operated by Agro-Greens Natural Products Ltd. (
Shelter Market ), whereby Embark will supply 2.0 concentrates, beverage and topical products to Shelter Market to sell into the medical market. New offerings launched in the coming weeks include the signature Hank Co. Bubble Hash and Pressed Hash combined with the innovative Distilled and Infused Nano Liquid Beverages and Meridian wellness topicals to follow in the subsequent weeks. We are proud to be launching our diverse portfolio of products and setting ourselves and our brands apart to ensure we have a leading position in the Medical Cannabis category. We look forward to providing Medical patients in Canada access to Cannabis 2.0 products, stated Dr. Luc C. Duchesne, Embark s CEO.
Article content
The concern is that, for certain individuals, exposure to the mould “may result in allergic symptoms such as sneezing, coughing, wheezing, runny nose or nasal congestion and watery or itchy eyes.” Additionally, exposure “may cause temporary adverse health consequences, where the probability of serious adverse health consequences is remote.” The notice advised that anything that has been opened should be discarded securely. / Photo by Consumer Product Recall notice
The notice emphasizes that “consumers should immediately stop using this product and return unopened product to the retailer where the product was purchased.” Anything that has been opened should be discarded securely.